Shots: The companies collaborated to identify targets for Otsuka’s therapeutics discovery programmes by leveraging PhoreMost’s expertise and next-generation phenotypic screening platform, SITESEEKER Otsuka will validate the novel targets identified in […]readmore
Shots: PhoreMost to receive upfront and research funding plus milestones and will utilize its expertise and phenotypic screening platform, SITESEEKER for the targets identified by BI and will be further […]readmore
Copyright © 2020 Digiqole. All Right Reserved.